These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3769134)

  • 21. Availability of epidemiologic data for chemicals known to cause cancer in animals: an update.
    Karstadt M
    Am J Ind Med; 1998 Nov; 34(5):519-25. PubMed ID: 9787859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemicals classified by IARC: their potency in tests for carcinogenicity in rodents and their genotoxicity and acute toxicity.
    McGregor DB
    IARC Sci Publ; 1992; (116):323-52. PubMed ID: 1428089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.
    Zeiger E
    Cancer Res; 1987 Mar; 47(5):1287-96. PubMed ID: 3815340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Vitro-In Vivo Carcinogenicity.
    Steinberg P
    Adv Biochem Eng Biotechnol; 2017; 157():81-96. PubMed ID: 27506831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IARC monographs, industry influence, and upgrading, downgrading, and under-grading chemicals: a personal point of view. International Agency for Research on Cancer.
    Huff J
    Int J Occup Environ Health; 2002; 8(3):249-70. PubMed ID: 12358081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compendium of chemical carcinogens by target organ: results of chronic bioassays in rats, mice, hamsters, dogs, and monkeys.
    Gold LS; Manley NB; Slone TH; Ward JM
    Toxicol Pathol; 2001; 29(6):639-52. PubMed ID: 11794380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The science and practice of carcinogen identification and evaluation.
    Cogliano VJ; Baan RA; Straif K; Grosse Y; Secretan MB; El Ghissassi F; Kleihues P
    Environ Health Perspect; 2004 Sep; 112(13):1269-74. PubMed ID: 15345338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of carcinogenicity bioassays in the IARC monographs.
    Cogliano VJ
    Ann N Y Acad Sci; 2006 Sep; 1076():592-600. PubMed ID: 17119235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of laboratory animal studies in estimating carcinogenic risks for man.
    Rall DP
    IARC Sci Publ (1971); 1979; (25):179-89. PubMed ID: 457152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of mechanistic data in the IARC evaluations of the carcinogenicity of polychlorinated biphenyls and related compounds.
    Lauby-Secretan B; Loomis D; Baan R; El Ghissassi F; Bouvard V; Benbrahim-Tallaa L; Guha N; Grosse Y; Straif K
    Environ Sci Pollut Res Int; 2016 Feb; 23(3):2220-9. PubMed ID: 26077316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medium-term bioassays for carcinogens.
    Ito N; Shirai T; Hasegawa R
    IARC Sci Publ; 1992; (116):353-88. PubMed ID: 1428090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carcinogenic properties of pharmaceutical agents evaluated in the IARC Monographs programme.
    Marselos M; Vainio H
    Carcinogenesis; 1991 Oct; 12(10):1751-66. PubMed ID: 1934255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The IARC Monographs on the carcinogenicity of crystalline silica.
    Guha N; Straif K; Benbrahim-Tallaa L
    Med Lav; 2011; 102(4):310-20. PubMed ID: 21834268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carcinogenicity testing of antitumor agents.
    Hottendorf GH
    Toxicol Pathol; 1985; 13(3):192-9. PubMed ID: 4070930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [International-cooperative studies on carcinogenicity evaluation of environmental chemicals].
    Hayashi Y
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):579-84. PubMed ID: 3985632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the carcinogenicity of chemicals: a review of the Monograph Program of the International Agency for Research on Cancer (1971 to 1977).
    Tomatis L; Agthe C; Bartsch H; Huff J; Montesano R; Saracci R; Walker E; Wilbourn J
    Cancer Res; 1978 Apr; 38(4):877-85. PubMed ID: 346205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a database on tumors and tumor sites in humans and in experimental animals for 'Group 1 agents identified through volume 109 of the
    Grosse Y; Lajoie P; Billard M; Krewski D; Rice J; Baan RA; Cogliano V; Bird M; Zielinski JM
    J Toxicol Environ Health B Crit Rev; 2019; 22(7-8):237-243. PubMed ID: 31612803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.